Li, Xue
Kim, Hyun Jung
Yoo, Jihwan
Lee, Yeonhee
Nam, Chang Hyun
Park, Jonghan
Lee, Soon-Tae
Kim, Tae Min
Choi, Seung Hong
Won, Jae-Kyung
Park, Sung‑Hye
Ju, Young Seok
Park, Jong Bae
Kim, Se Hoon
Chang, Jong Hee
Wu, Hong-Gyun
Park, Chul-Kee
Lee, Jeong Ho
Kang, Seok-Gu
Lee, Joo Ho
Funding for this research was provided by:
National Research Foundation of Korea (2019R1A3B206661923)
National Research Foundation of Korea (2022R1A2B5B03001199)
National Research Foundation of Korea (2021R1A2C1095168)
Korea Health Industry Development Institute (HI23C1573)
Article History
Received: 18 October 2024
Accepted: 15 February 2025
First Online: 4 March 2025
Declarations
:
: Human sample collection: all samplings were approved by Seoul National University Hospital (IRB#H-1907-103-1048 and #H-0507-509-153) and Yonsei University Severance Hospital (IRB# 4-2021-1319). Mouse experiments: All procedures were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee at Seoul National University Hospital (SNUH-IACUC).
: Jeong Ho Lee is a co-founder and chief scientific officer of Sovargen Inc.